NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Randy F Sweis
University of Chicago - Chicago / United States
Medical and Health Sciences / Immunology
AD Scientific Index ID: 1850665
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Randy F Sweis's MOST POPULAR ARTICLES
1-)
WNT/β-catenin pathway activation correlates with immune exclusion across human cancersJJ Luke, R Bao, RF Sweis, S Spranger, TF GajewskiClinical Cancer Research 25 (10), 3074-3083, 20194302019
2-)
T cell–inflamed versus non-T cell–inflamed tumors: a conceptual framework for cancer immunotherapy drug development and combination therapy selectionJA Trujillo, RF Sweis, R Bao, JJ LukeCancer immunology research 6 (9), 990-1000, 20182932018
3-)
Molecular drivers of the non–T-cell-inflamed tumor microenvironment in urothelial bladder cancerRF Sweis, S Spranger, R Bao, GP Paner, WM Stadler, G Steinberg, ...Cancer immunology research 4 (7), 563-568, 20163012016
4-)
Phase I dose-escalation trial of MIW815 (ADU-S100), an intratumoral STING agonist, in patients with advanced/metastatic solid tumors or lymphomasF Meric-Bernstam, RF Sweis, FS Hodi, WA Messersmith, RHI Andtbacka, ...Clinical cancer research 28 (4), 677-688, 20221892022
5-)
Silver-catalyzed [2+ 2] cycloadditions of siloxy alkynesRF Sweis, MP Schramm, SA KozminJournal of the American Chemical Society 126 (24), 7442-7443, 20041572004
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept